Diabetes Mellitus, Type 2: all 9,589 studies
Page 89 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- Reandron in Diabetic Men Witn Low Testosterone LevelCompletedNCT00613782Phase 2/3
- Beta-Cell Function After Near-Normalisation of Blood GlucoseCompletedNCT00612950Not applicable
- A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 DiabetesCompletedNCT00612794Phase 1
- Near Normalisation of BG Improves the Potentiating Effect of GLP-1CompletedNCT00612625Not applicable
- Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 DiabetesCompletedNCT00612599Phase 3
- Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DMCompletedNCT00612144Phase 4
- Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 DiabetesCompletedNCT00609856Phase 4
- Antioxidant Treatment of Type 2 DiabetesCompletedNCT00609102Early Phase 1
- Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American IndiansCompletedNCT00608387Not applicable
- Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes MellitusCompletedNCT00607945Phase 1
- First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050CompletedNCT00607906Phase 1
- TTA in Treatment of Diabetes and DyslipidemiaCompletedNCT00605787Phase 2
- A Drug Interaction Study Between Simvastatin and GSK376501CompletedNCT00605449Phase 1
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 DiabetesCompletedNCT00605111Phase 4
- Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00605020Phase 3
- Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesCompletedNCT00604396Phase 3
- Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy AloneCompletedNCT00604253Phase 3
- Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 DiabetesCompletedNCT00600626Phase 3
- Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 DiabetesCompletedNCT00600366Phase 4
- HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican PopulationWithdrawnNCT00600236Phase 3
- Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyCompletedNCT00598793Phase 3
- Pilot Study to Assess Pre-packaged, Portion-controlled Meal Plan on Weight LossCompletedNCT00593476Not applicable
- Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 DiabetesCompletedNCT00593255Phase 4
- Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00592969Phase 4
- Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 DiabetesCompletedNCT00592527Phase 3
- Genetic Variation in OCT1 and Response to MetforminWithdrawnNCT00588172Phase 4
- Exenatide Pregnancy Registry - Type 2 Diabetes in PregnancyTerminatedNCT00579150
- Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With InsulinCompletedNCT00576784Phase 4
- Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00575874Phase 2
- Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00575471Phase 2
- Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1CompletedNCT00574665Not applicable
- Effects of Cilostazol on Plasma Adipocytokine and Arterial StiffnessStatus unknownNCT00573950Phase 4
- Initiation of Insulin Aspart in Type 2 DiabetesCompletedNCT00572806Phase 4
- Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired PatientsCompletedNCT00572650Phase 1
- Comparison of Glycemic Control Achieved With 2 Different NeedlesCompletedNCT00572052Phase 4
- Effect of Thiazolidinedione Treatment Vascular Risk MarkersCompletedNCT00571506Phase 4
- Computer Based Intervention for Type 2 Diabetes in YouthCompletedNCT00570466Not applicable
- Comparison of Two Pen Systems in Patients With Diabetes Treated With InsulinCompletedNCT00569998Phase 3
- Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With ExenatideCompletedNCT00569907
- N-Acetylcysteine and Arginine Administration in Diabetic PatientsTerminatedNCT00569465Phase 4
- Evaluating the Use of Two Different Needles in Subjects With DiabetesCompletedNCT00569426Phase 4
- Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 DiabetesCompletedNCT00568984Phase 4
- The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes MellitusCompletedNCT00568620Not applicable
- Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 DiabetesCompletedNCT00568074Phase 4
- Effect of Green Tea Extract on Type 2 DiabetesCompletedNCT00567905Phase 2/3
- Drug-Drug Interaction Study of Mitiglinide and GemfibrozilCompletedNCT00566865Phase 1
- The Effect of Ethanol on Overnight Glucose Regulation in Type 2CompletedNCT00566592Not applicable
- Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal ExclusionCompletedNCT00566358Phase 1/2
- Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal StudyTerminatedNCT00566215Phase 1/2
- New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade ICompletedNCT00566189Phase 2/3
- A Pilot Study of Metabolic Effects of OmentectomyTerminatedNCT00565799Phase 2
- Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 DiabetesCompletedNCT00564668Phase 3
- Effect of Increased Intake of Low Fat Dairy Products on Weight Loss and Insulin ResistanceCompletedNCT00564551Not applicable
- 20 Week Bridging Study in Type II DMCompletedNCT00563225Phase 3
- The Effect of DBcare, a Food Supplement on Diabetes ControlCompletedNCT00563004Not applicable
- Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy SubjectsCompletedNCT00562250Phase 1
- Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)CompletedNCT00562172Phase 4
- Study of Duodenal-Jejunal Bypass(DJB) as a Potential Cure for Type 2 Diabetes MellitusCompletedNCT00562029Not applicable
- Adiponectin in Obese Women With T2DN and Effects by RAS BlockerCompletedNCT00561704Not applicable
- Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With AlbuminuriaCompletedNCT00561171Phase 2
- A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy SubjectsCompletedNCT00559884Phase 1
- Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood VesselsTerminatedNCT00559286Phase 4
- 4 Weeks Treatment of Type II Diabetic Patients With BI 44847CompletedNCT00558909Phase 1
- AI(I)DA Acarbose and the Subclinical InflammationCompletedNCT00558883Phase 3
- Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic NephropathyCompletedNCT00556465Phase 2/3
- Diabetes Mellitus Type II and Tissue OxygenationTerminatedNCT00554697
- Renal Impairment in Type 2 Diabetic SubjectsCompletedNCT00554450Phase 1
- Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 DiabetesCompletedNCT00553020Phase 4
- Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart DiseaseStatus unknownNCT00552903Phase 3
- Glycemic Optimization Treatment StudyCompletedNCT00552370Phase 4
- Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes MellitusCompletedNCT00552227Phase 1
- Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 DiabetesCompletedNCT00551954Phase 3
- Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)CompletedNCT00551876Phase 3
- Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes MellitusCompletedNCT00551590Phase 1
- Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone MaleateCompletedNCT00551564Phase 1
- 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. GlargineCompletedNCT00551538Phase 4
- Lispro Mix 25 vs. Glargine in Type 2 DiabeticsCompletedNCT00551356Phase 3
- Bioequivalence Study Of Glucotrol XL 2.5 Mg TabletsCompletedNCT00550329
- To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00550095Phase 4
- An Observational Study Evaluating Patient Satisfaction and Quality of Life Associated With Switching InsulinCompletedNCT00549887
- Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 DiabetesCompletedNCT00549874Not applicable
- Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing AtenololCompletedNCT00549133Phase 4
- Paleolithic Diets vs T2D and Improvements in the Metabolic SyndromeCompletedNCT00548782Not applicable
- Effect of Pioglitazone Therapy for Type 2 Diabetes on VisionCompletedNCT00548158
- The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized StudyTerminatedNCT00547482Not applicable
- Dyslipidemia in Type 2 Diabetes (0767-034)TerminatedNCT00547274Phase 3
- Promoting Physical Activity Among Patients With Type 2 DiabetesCompletedNCT00547027Phase 2/3
- REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic AgentsCompletedNCT00546325Phase 3
- Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic PatientsStatus unknownNCT00544518Phase 2
- Comparison of Enteral Products for Tube Fed Patients With Type 2 DiabetesCompletedNCT00544206Phase 2
- Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)TerminatedNCT00543959Phase 2
- MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)TerminatedNCT00543816Phase 3
- Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)TerminatedNCT00543751Phase 3
- An Intervention Program to Control DiabetesCompletedNCT00543621Phase 4
- MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)CompletedNCT00543595Phase 2
- MK0767 in Type 2 Diabetes (0767-012)TerminatedNCT00543556Phase 2
- Study A - MK0767 Monotherapy StudyTerminatedNCT00543517Phase 3
- MK0767 and Sulfonylurea Combination Study (0767-027)TerminatedNCT00543491Phase 3
- Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)TerminatedNCT00543361Phase 3
- MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)TerminatedNCT00543010Phase 3